Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
Date:11/3/2008

is of the results of the Phase I trial, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
2. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
3. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
4. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
5. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
6. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
7. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
8. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
9. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
10. Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... N.Y., Dec. 3 Nikon Corporation, an innovator ... has signed a licensing agreement with Harvard University ... Optical Reconstruction Microscopy (STORM) technology. Under the terms ... microscopy systems and market them with the N-STORM ...
(Date:12/3/2009)... Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger ... of $3.00 per share on its Series B Convertible Perpetual ... shares of Series B stock in an amount per share ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Neurostimulation - A Global ... ,, The world neurostimulation market stands ... population, and the resultant rise in age-related ...
(Date:12/2/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... and dosimetry trial of Cotara® in patients with relapsed ... Cotara is a targeted monoclonal antibody linked to ... for GBM. Cotara specifically targets cells at the ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... CLAREMONT, Calif., Oct. 2 Kiwa,Bio-Tech Products Group Corporation ... Feed Limited Liability Company, located in,Wuqing District in Tianjin, ... September. Mr. Wei Li, Chairman and CEO of ... of Kiwa,s bio-feed products to approximately 7,550 tons,during the ...
... Choice in All Lines ... Decision Resources, WALTHAM, Mass., Oct. 2 ... advisory firms focusing on pharmaceutical and,healthcare issues, finds ... doctor specialty. According to the new report entitled,Treatment ...
... 2 GeneGo, Inc., the leading,systems biology tools company, ... of Akzo Nobel, have extended their GeneGo,software and database ... also added MetaLink so that they can upload their ... MetaCore,s manually,curated content. GeneGo offers easy to use ...
Other Biology Technology:Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month 2Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer 2Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer 3Organon Extends MetaCore License and Adds MetaLink 2
(Date:12/4/2009)... AgriLife Research plant physiologist at the Texas AgriLife Research ... to help vegetable plants make a less stressful transition ... can aid in the successful production and possibly even ... high-quality, more adaptive plants that will establish well," Leskovar ...
(Date:12/4/2009)... is available in German . , A ... Ageing could help to understand the positive effect of dietary ... flies and mice) have shown that dietary restriction increases longevity, ... So the female fruit fly reproduces less frequently with a ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2U S Issues Swine Flu Guidelines for Day Care Programs 56270 1U S Issues Swine Flu Guidelines for Day Care Programs 56270 2U S Issues Swine Flu Guidelines for Day Care Programs 56270 3Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 1Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 2263 Regulatory Professionals Achieve RAC Certification 13864 1263 Regulatory Professionals Achieve RAC Certification 13864 2263 Regulatory Professionals Achieve RAC Certification 13864 3
... A UCL (University College London) study has found that you ... think too hard and instead trust your instincts. The research, ... in some cases, instinctive snap decisions are more reliable than ... asked to pick the odd one out on a screen ...
... that detect only one type of stimuli, our sense of ... to improve how we smell, according to University of Pennsylvania ... Neuroscience. , This finding, plus the fact that both ... control how our brain perceives what we smell, explains why ...
... global warming affect ocean circulation and sea levels in the ... Why are dead zones in the oceans on the rise? ... to blame for the collapse of coastal fisheries? , Most ... , Members of the news media are invited to ...
Other Biology News:Trusting your instincts leads you to the right answer 2Trusting your instincts leads you to the right answer 3Penn study on olfactory nerve cells shows why we smell better when we sniff 2Are we killing the world's oceans? 2
Ready-to-use solution....
...
... Polyclonal Antibody Production Conjugated peptides ... ten-week protocol to produce antibodies in 2 ... ml antiserum) ELISA test until the titer ... reaches target titer Protein G purification ...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: